Results 131 to 132 of about 69,398 (132)
Some of the next articles are maybe not open access.

New Drug: Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease

Australian Prescriber, 2019
exaly  

Cerliponase Alfa for the Treatment of CLN2 Disease in a Patient Cohort Including Children under 3 Years

Neuropediatrics
Angela Schulz   +2 more
exaly  
3. good health
dipeptidyl-peptidases and tripeptidyl-peptidases
recombinant proteins
humans
neuronal ceroid-lipofuscinoses
enzyme replacement therapy
tripeptidyl-peptidase 1
child
child, preschool
previous   12  13  14  

Home - About - Disclaimer - Privacy